
| Publication |
|---|
| Beyond medical actionability: Public perceptions of important actions in response to hypothetical genetic testing results. Seiffert David J et al. Journal of genetic counseling 2019 Feb |
| ETHICAL AND GENETIC ASPECTS REGARDING PRESYMPTOMATIC TESTING FOR NEURODEGENERATIVE DISEASES. Rev Med Chir Soc Med Nat Iasi. 2016 Jan-Mar;120(1):15-22. |
| Personal utility in genomic testing: is there such a thing? Bunnik Eline M et al. Journal of medical ethics 2015 Apr 41(4) 322-6 |
| Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials. Kim Scott Y H et al. Neurology 2015 Mar 11. |





No hay comentarios:
Publicar un comentario